Gentamicin Sulfate Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Gentamicin Sulfate Price Trend, Index and Forecast
Track the latest insights on gentamicin sulfate price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Gentamicin Sulfate Prices Outlook Q3 2025:
- USA: USD 148177/MT
- China: USD 110313/MT
- Germany: USD 167118/MT
- Netherlands: USD 109174/MT
- Mexico: USD 126560/MT
Gentamicin Sulfate Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the gentamicin sulfate prices in the USA reached 148177 USD/MT in September. The US market registered a pronounced downward correction driven primarily by softer demand from institutional buyers and a lull in large tender awards. Procurement cycles in the healthcare sector moved toward contract renewals with lower accepted bid levels, encouraging distributors to run down inventories rather than replenish at prior price benchmarks.
During the third quarter of 2025, the gentamicin sulfate prices in China reached 110313 USD/MT in September. China’s market reflected a marked price contraction amid excess finished-goods availability at domestic formulators and constrained export demand from several regional buyers. Producers responded to weaker offtake by extending commercial volumes into secondary markets, putting further pressure on factory gate pricing.
During the third quarter of 2025, the gentamicin sulfate prices in Germany reached 167118 USD/MT in September. The German market experienced downward pricing momentum as hospital procurement committees prioritized cost containment and many long-term supply agreements were re-priced during renewal windows. Domestic API manufacturers faced muted demand from generics producers who were reducing batch sizes in response to lower global tender activity, translating into reduced orderbooks and clearance selling.
During the third quarter of 2025, the gentamicin sulfate prices in the Netherlands reached 109174 USD/MT in September. Dutch market dynamics showed clear downward pressure as trading firms and distributors reacted to a softening European procurement environment. Centralized tenders across the region delayed new purchases pending revised budget approvals, causing buyers to deplete existing stocks rather than initiate fresh orders. Parallel increases in tender competitiveness and the entry of additional secondary suppliers led to more aggressive pricing for spot volumes.
During the third quarter of 2025, the gentamicin sulfate prices in Mexico reached 126560 USD/MT in September. Mexico’s market showed a decline in pricing, driven by public procurement cycles that favored lower-cost bids and by private sector customers delaying discretionary purchases. Cross-border supply from neighboring suppliers increased competitive pressure on local producers, while distributors prioritized clearing older stocklots to preserve working capital.
Gentamicin Sulfate Prices Outlook Q2 2025
- USA: USD 163730/MT
- China: USD 119000/MT
- Germany: USD 171400/MT
- Netherlands: USD 123500/MT
- Mexico: USD 131150/MT
During the second quarter of 2025, gentamicin sulfate prices in the USA reached 163730 USD/MT in June. Gentamicin sulfate prices in the US stayed firm, supported by consistent demand in human and veterinary healthcare. Rising manufacturing expenses, stricter compliance requirements, and transportation bottlenecks constrained supply, contributing to upward pricing pressure. Regulatory oversight continued to elevate production costs, while stable consumption ensured demand strength. The combination of high input costs and logistical hurdles sustained a steady price environment throughout the quarter, with the US market reflecting resilience despite persistent supply-side challenges.
During the second quarter of 2025, gentamicin sulfate prices in China reached 119000 USD/MT in June. Gentamicin sulfate prices in China showed persistent firmness, supported by strong export activity and robust domestic demand. Production costs rose due to higher raw material and energy expenses, while tighter regulatory enforcement added further supply-side constraints. Pharmaceutical and veterinary sectors sustained demand, ensuring consistent consumption. With supply chains facing intermittent disruptions, market sentiment stayed bullish. As a leading global supplier, China’s pricing trends influenced broader regional dynamics, keeping prices elevated and reflecting the balance between strong demand and restricted availability.
During the second quarter of 2025, the gentamicin sulfate prices in Germany reached 171400 USD/MT in June. Germany’s gentamicin sulfate market maintained a firm pricing outlook, supported by regulatory stringency and elevated production expenses. Energy price increases and higher operational costs added pressure on manufacturers, while strict compliance standards limited flexibility in supply. Demand from both pharmaceutical and veterinary sectors remained steady, further reinforcing pricing stability. Supply chain inefficiencies and cost burdens kept the market environment tight, ensuring prices stayed strong. Germany’s market reflected broader European trends, where stringent regulations and cost challenges shaped sustained firmness in gentamicin sulfate prices.
During the second quarter of 2025, the gentamicin sulfate prices in the Netherlands reached 123500 USD/MT in June. Gentamicin sulfate prices in the Netherlands likely followed broader European trends, with firm pricing driven by elevated production and compliance costs. Import dependency added pressure, as sourcing from other EU countries and global suppliers faced delays and rising logistics expenses. Healthcare and veterinary demand stayed consistent, but supply-side constraints limited market flexibility. Regulatory oversight and operational burdens reinforced the cost structure, resulting in steady pricing sentiment. The Netherlands thus mirrored regional conditions, where strong demand and constrained supply maintained a firm price environment.
During the second quarter of 2025, the gentamicin sulfate prices in Mexico reached 131150 USD/MT in June. Mexico’s gentamicin sulfate market showed steady pricing trends, largely influenced by US supply dynamics and import dependence. Rising global production costs and transportation expenses pushed up overall supply chain burdens. Consistent demand from the healthcare and veterinary sectors ensured stable consumption levels, reinforcing market firmness. Regulatory oversight and limited domestic production capacity further contributed to reliance on imports. As a result, Mexican pricing aligned with international trends, remaining stable but under upward pressure due to elevated costs and cross-border sourcing challenges.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing gentamicin sulfate prices.
Europe Gentamicin Sulfate Price Trend
Q3 2025:
European gentamicin sulfate markets showed a pronounced downward drift as centralized procurement and coordinated tender activity across multiple countries intensified buyer leverage. Tender committees prioritized cost containment, prompting suppliers to undercut previous price references to win framework agreements. Secondary trading increased as distributors sought to reallocate excess stocks across borders, thereby suppressing spot prices. Logistics improvements and steady availability of input chemicals removed premium cost layers, encouraging more aggressive commercial offers.
Q2 2025:
As per the gentamicin sulfate price index, European gentamicin sulfate prices remained firm, shaped by strong demand from the pharmaceutical and veterinary sectors. High production expenses, driven by energy costs and strict environmental regulations, placed sustained pressure on manufacturers. Supply was further tightened by dependency on imports from Asia, where rising export commitments reduced availability. Despite these challenges, healthcare demand remained resilient, ensuring stable consumption. Overall, the European market experienced elevated prices through the quarter, reflecting the combined effects of strong demand, regulatory pressure, and supply-side limitations.
This analysis can be extended to include detailed gentamicin sulfate price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Gentamicin Sulfate Price Trend
Q3 2025:
North American regional pricing for gentamicin sulfate moved lower due to a combination of softer hospital tenders and larger distributors reducing procurement at earlier, higher benchmarks. Contract renewals favored lower unit pricing and spot buyers pushed for immediate concessions, leading to greater downward adjustment in list prices. Cross-border supply from multiple sourcing hubs alleviated local shortages and improved availability at competitive landed costs, removing prior upward pressure from logistics constraints.
Q2 2025:
North America maintained firm gentamicin sulfate pricing, largely supported by consistent demand across healthcare and veterinary sectors. Regulatory compliance standards and elevated manufacturing costs continued to play a critical role in shaping market trends. Supply chain inefficiencies and transportation challenges added to the pressure, preventing any major easing of prices. The market remained stable, reflecting resilience despite ongoing challenges. Overall, North America’s pricing environment was characterized by strong demand, high operating costs, and steady alignment with global upward momentum.
Specific gentamicin sulfate historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Gentamicin Sulfate Price Trend
Q3 2025:
The report explores the gentamicin sulfate trends and gentamicin sulfate price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
Q2 2025:
As per the gentamicin sulfate price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
In addition to region-wise data, information on gentamicin sulfate prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Gentamicin Sulfate Price Trend
Q3 2025:
Asia Pacific markets experienced downward price momentum driven by elevated finished-goods inventories at several large manufacturing hubs and softer export demand from key buyers. Producers adopted pragmatic pricing to clear stock and sustain production rates, offering more competitive spot volumes. Regional logistics improvements and normalization of upstream chemical supplies reduced previously elevated input cost pressure, enabling suppliers to accept narrower margins. Tender windows in several markets produced conservative procurement quantities, reinforcing buyer leverage and contributing to a pervasive decline in regional price levels over the quarter.
Q2 2025:
Gentamicin sulfate prices in the Asia Pacific strengthened, with China playing a key role in shaping regional market sentiment. Rising production costs, including raw material and energy expenses, supported the upward movement. Demand from both pharmaceutical manufacturers and veterinary applications remained strong, further tightening the supply-demand balance. Export commitments from leading producing nations also limited regional availability. Overall, APAC experienced a bullish pricing environment, driven by robust consumption and supply-side constraints, establishing the region as a crucial driver of global market dynamics.
This gentamicin sulfate price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Gentamicin Sulfate Price Trend
Q3 2025
Latin American gentamicin sulfate pricing trended lower as public procurement agencies implemented stricter budget discipline and private buyers postponed discretionary purchases. Cross-border competition from surplus export volumes exerted downward pressure on local quotations, while distributors prioritized liquidity by offering lower prices to move existing inventory. Freight cost normalization and improved port operations reduced incremental landed costs, removing a factor that had previously supported price resilience.
Q2 2025:
The gentamicin sulfate market in Latin America showed steady firmness, primarily due to its reliance on imports. Prices were influenced by supply trends in Asia and North America, where rising production and compliance costs shaped global availability. Logistics challenges and regulatory complexities in several countries further contributed to cautious supply conditions. Demand from the pharmaceutical and veterinary sectors remained stable, preventing major fluctuations. Overall, the regional market reflected moderate firmness, guided more by global supply patterns than local production.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Gentamicin Sulfate Pricing Report, Market Analysis, and News
IMARC's latest publication, “Gentamicin Sulfate Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the gentamicin sulfate market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of gentamicin sulfate at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed gentamicin sulfate prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting gentamicin sulfate pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Gentamicin Sulfate Industry Analysis
The global gentamicin sulfate market size reached USD 556.6 Million in 2025. By 2034, IMARC Group expects the market to reach USD 722.1 Million, at a projected CAGR of 2.93% during 2026-2034. The market is primarily driven by the widespread product adoption in the treatment of complicated urinary tract infections, the global rise in healthcare expenditure, and shifts in institutional procurement strategies.
Latest News and Developments:
- March 2025: A recent study reported that embedding submicron gentamicin sulfate particles into UHMWPE significantly enhanced both antibiotic release and mechanical performance. Researchers found that blends containing these finer particles delivered stronger tensile and impact properties than formulations using larger particles. The submicron-loaded UHMWPE also released antibiotics more effectively and for a longer duration. The findings underscored the material’s potential to improve therapeutic orthopedic implants, offering a promising strategy for strengthening spacers while supporting infection management in joint replacement patients.
Product Description
Gentamicin sulfate is an aminoglycoside antibiotic derived from Micromonospora purpurea, a type of actinobacteria. It is commonly used to treat a variety of bacterial infections. The compound is typically available in the form of a white to off-white powder that is soluble in water. As an aminoglycoside, gentamicin sulfate works by inhibiting bacterial protein synthesis, which ultimately leads to the death of susceptible bacteria.
It is widely used in both human and veterinary medicine due to its broad-spectrum antibacterial properties. In human medicine, it is often employed to treat severe infections such as septicemia, respiratory tract infections, urinary tract infections (UTIs), and infections of the bones and joints. Additionally, gentamicin sulfate is frequently used in combination with other antibiotics to enhance its effectiveness and broaden the scope of bacterial coverage.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Gentamicin Sulfate |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Gentamicin Sulfate Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of gentamicin sulfate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting gentamicin sulfate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The gentamicin sulfate price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.